NOX 0.00% 11.5¢ noxopharm limited

FDA orphan designation for idronoxil, page-8

  1. 392 Posts.
    lightbulb Created with Sketch. 132
    Hey Guys, just a moment. Are we sure this is a positive approval?

    On a second read-through I noticed this line….

    FDA Orphan Approval Status: Not FDA Approved for Orphan Status.

    Now I would be ecstatic if the positive reading is correct …but this line above seems a touch ambiguous don’t you think?

    Could it mean Not Approved ….or maybe just …Not Approved Yet?

    Hmmmmm?

    Apples

    Search Orphan Drug Designations and Approvals

    -
    Column 1 Column 2
    0 Generic Name: Idronoxil
    1 Date Designated: 03/17/2022
    2 Orphan Designation: Treatment of soft tissue sarcomas (STS)
    3 Orphan Designation Status: Designated
    4 FDA Orphan Approval Status: Not FDA Approved for Orphan Indication
    5 Sponsor: Noxopharm LimitedLevel 20, Tower A, The Zenith821 Pacific HwyChatswood, NSW 2067Australia The sponsor address listed is the last reported by the sponsor to OOPD.
    *Exclusivity Protected Indications are shown for approvals from Jan. 1, 2013, to the present.
 
watchlist Created with Sketch. Add NOX (ASX) to my watchlist
(20min delay)
Last
11.5¢
Change
0.000(0.00%)
Mkt cap ! $33.60M
Open High Low Value Volume
11.0¢ 12.0¢ 10.5¢ $84.79K 771.7K

Buyers (Bids)

No. Vol. Price($)
6 179890 10.0¢
 

Sellers (Offers)

Price($) Vol. No.
11.5¢ 349534 1
View Market Depth
Last trade - 16.10pm 12/09/2024 (20 minute delay) ?
NOX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.